Table 3.
Non-telomeric roles of Reptin in cancer
| Reptin | Cell/tissue Type(s) | Functional outcome | Ref |
|---|---|---|---|
| Controlling the chromatin structure | Breast cancer cell lines | Increased cyclin D1 expression and enhanced cell proliferation | [129] |
| Forms complex with β-catenin | Prostate cancer | Reduces expression of KAI1 tumor suppressor gene and increases cell growth | [130] |
| Decondenses the chromatin | Xenopus embryos, Ovarian cancer cell line | Increases cell proliferation | [131, 132] |
| Interacts with the wild-type p53 | Non-small cell lung carcinoma and breast cancer cell lines | Inhibits expression of p53-dependent genes, increases cell proliferation and metastasis | [135–138] |
| Inhibits p14ARF | Non-small cell lung carcinoma and breast cancer cell lines | leads to activation of MDM2 and destabilization of p53 that causes enhanced proliferation | [138, 139] |
| Methylated Reptin recruits HDAC1 to the promoters | breast cancer cell lines | Regulates expression of hypoxia genes | [142] |